Toshifumi Mikayama

Director/Board Member en KYOWA KIRIN CO. LTD. .

66 años

Health Technology

Perfil

Toshifumi Mikayama has held positions as a Director at Kyowa Kirin International Plc since 2012 and as a Director & Vice President at Kyowa Kirin Co., Ltd.
since 2008.

Cargos activos de Toshifumi Mikayama

Empresas	Cargo	Inicio
KYOWA KIRIN CO. LTD.	Director/Board Member	01/03/2014
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Director/Board Member	07/03/2012

Todos los cargos activos de Toshifumi Mikayama

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Toshifumi Mikayama.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
KYOWA KIRIN CO. LTD.	Health Technology

Empresas privadas	1
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Health Technology